Tradestie Institutional Equity Comparison Engine
SGHT vs BMRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGHT Overall Edge
SGHT Captures Institutional Edge (3โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sight Sciences, Inc. Common Stock (SGHT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGHT trades at N/M Forward P/E with -20.2% operating margin (+25.2% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, SGHT sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SGHT N/M vs BMRA N/M Fwd P/E
Growth & Margin Winner
SGHT
Op Margin -20.2% vs -125.2% ยท YoY +25.2% vs -8.3%
Momentum & Technical Winner
SGHT
1Y +50.6% vs -46.9% ยท 52W Pos 88% vs 4%
Options & Structure Winner
SGHT
BREAKOUT (8th %ile IV) vs UNCLASSIFIED (N/A IV)
SGHT
NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.62
-1.94% 1D
Market Cap
$610.8M
1M Return
+28.26%
1Y Return
+50.64%
Forward P/E
N/M
Unified AI Score
35.1 / 100
SELL
Tech 50.0
Fund 32.0
Flow 57.0
Mom 50.0
BMRA
NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap
$6.0M
1M Return
-28.19%
1Y Return
-46.86%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 40.0
Fund 47.0
Flow 50.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SGHT +50.64%
BMRA -46.86%
Spread: +97.5 pp (SGHT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SGHT Revenue | BMRA Revenue | SGHT Op. Margin | BMRA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $10M | N/A | -46.4% | BMRA |
| FY2020 | $30M | $10M | -116.5% | -41.0% | BMRA |
| FY2021 | $50M | $10M | -105.2% | -104.2% | BMRA |
| FY2022 | $70M | $20M | -117.7% | -24.0% | BMRA |
| FY2023 | $80M | $10M | -70.7% | -135.3% | SGHT |
| FY2024 | $80M | $10M | -63.3% | -117.6% | SGHT |
| FY2025 | $80M | $10M | -48.0% | -96.7% | SGHT |
| FY2026 | N/A | $0M | N/A | -119.5% | BMRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGHT | BMRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $610.8M | $6.0M | Larger Scale | SGHT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +25.2% | -8.3% | Higher Growth | SGHT |
| Operating Margin (TTM) Profitability | -20.2% | -125.2% | Higher Margin | SGHT |
| Net Profit Margin Profitability | -32.1% | -115.5% | Higher Margin | SGHT |
| Return on Equity (ROE) Capital Efficiency | -50.1% | -113.8% | Higher ROE | SGHT |
| 52-Week Range Position Momentum | 88% ($3โ$12) | 4% ($1โ$3) | Stronger Trend | SGHT |
| Beta / 30D Volatility Risk Regime | 1.06ฮฒ ยท 46% Vol | 0.67ฮฒ ยท 62% Vol | Lower Realized Risk | SGHT |
| Unified Institutional Score Composite Signal | 35.1 / 100 (SELL) | 44.5 / 100 (HOLD) | Higher Composite | BMRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SGHT vs BMRA Buy Guide
SGHT
BREAKOUT
33d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
BMRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SGHT nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.